Temporary Denosumab Discontinuation Promotes Bone Healing of Osteonecrosis of the Jaw and Minimizes the Invasiveness of Surgery: A Case Presentation
Denosumab has proved effective at low doses in increasing bone mineral density in osteoporosis patients. In contrast to high-doses antiresorptive therapy, denosumab has a transient effect on the inhibition of the bone remodeling process, suggesting that denosumab-related osteonecrosis is a self-limi...
| Auteurs principaux: | , , , |
|---|---|
| Format: | Article |
| Langue: | English |
| Publié: |
MDPI AG
2022-02-01
|
| Collection: | Oral |
| Sujets: | |
| Accès en ligne: | https://www.mdpi.com/2673-6373/2/1/6 |